Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-24T03:59:43.000Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic Malignant Syndrome and Heart Stroke

Published online by Cambridge University Press:  29 January 2018

Gerard Addonizio  and
Virginia Susman
Gerard Addonizio
Affiliation:
Cornell University Medical College and Westchester Division, The New York Hospital, N. Y. 10605
Virginia Susman
Affiliation:
Cornell University Medical College and Westchester Division, The New York Hospital, N. Y. 10605
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 145 , Issue 5 , November 1984 , pp. 556 - 557
Copyright
Copyright © 1984 The Royal College of Psychiatrists 

References

Ayd, F. R. Jr. (1983) Bromocriptine therapy for the neuroleptic malignant syndrome. International Drug Therapy Newsletter, 18, 33–36.Google Scholar
Caroff, S. N. (1980) The neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 41, 79–83.Google ScholarPubMed
Smego, R. A. Jr. & Durack, D. T. (1982) The neuroleptic malignant syndrome. Archives of Internal Medicine, 142, 1183–1185.CrossRefGoogle ScholarPubMed
Szabadi, E. (1984) Neuroleptic malignant syndrome. British Medical Journal, 288, 1399–1400.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.